0.353
3.29%
-0.012
시장 영업 전:
.32
-0.033
-9.35%
Enveric Biosciences Inc (ENVB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
22.97%
0.000696
|
0.000566 | 0.00224 | 0.000916 | -0.000011 |
Operating Expenses
|
3.90%
2.478
|
2.3849 | 3.4506 | 5.7559 | 4.8607 |
Benefits Costs and Expenses |
28.07%
2.4559
|
3.4142 | 2.8179 | - | - |
Costs And Expenses |
28.07%
2.4559
|
3.4142 | 2.8179 | 5.7559 | 4.8607 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Depreciation and Amortization |
0.86%
0.0854
|
0.0847 | 0.0863 | 0.0865 | 0.0865 |
Operating Income/Loss |
3.90%
-2.4773
|
-2.3844 | -3.4484 | -5.755 | -4.8607 |
Net Interest Income/Expense |
22.97%
0.000696
|
0.000566 | 0.00224 | 0.000916 | -0.000011 |
Nonoperating Income/Loss |
102.15%
0.0221
|
-1.0293 | 0.6328 | -0.601 | 0.1832 |
Income/Loss From Continuing Operations Before Tax |
28.08%
-2.4552
|
-3.4136 | -2.8156 | -6.3561 | -4.6775 |
Income/Loss From Continuing Operations After Tax |
28.68%
-2.4552
|
-3.4425 | -2.8156 | -6.3561 | -4.6775 |
Net Income/Loss
|
28.49%
-2.4569
|
-3.4359 | -2.8222 | -6.3561 | -4.6775 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
9,448%
4.0015
|
0.0419 | 2.1647 | 2.1076 | 2.0783 |
Diluted Average Shares |
9,448%
4.0015
|
0.0419 | 2.1647 | 2.1076 | -0.0146 |
Basic Earnings Per Share |
58.50%
-0.61
|
-1.47 | -1.30 | -3.04 | -2.31 |
Diluted Earnings Per Share |
58.50%
-0.61
|
-1.47 | -1.30 | -3.04 | -2.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):